Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Sciences|September 27, 2025
Unveiling Cryptic <i>BCR-ABL1</i> Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid MalignanciesAnna Ferrari, Chiara Salvesi, Eugenio Fonzi, et al.BMC Infectious Diseases|February 8, 2017
Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?Antonio Di Biagio, Marta Ameri, Davide Sirello, et al.Journal of the International AIDS Society|November 14, 2014
Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) studyAlberto Venturini, Barbara Giannini, Marcello Montefiori, et al.ERJ Open Research|February 8, 2018
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharingNiccolò Riccardi, Barbara Giannini, Maria Lucia Borghesi, et al.Clinical Chemistry|September 23, 2003
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLCMichele Bianchini, Emanuela Ottaviani, Tiziana Grafone, et al.Studies in Health Technology and Informatics|May 21, 2015
IANUA: a regional project for the determination of costs in HIV-infected patientsBarbara Giannini, Roberta Gazzarata, Patrizia Orcamo, et al.Cancers|April 14, 2025
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct GenotypeMichela Rondoni, Giovanni Marconi, Annalisa Nicoletti, et al.Blood Advances|October 19, 2020
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AMLGiuseppe Visani, Federica Loscocco, Mike Dennis, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 3, 2023
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patientsMartina Ghetti, Ivan Vannini, Maria Teresa Bochicchio, et al.Blood|May 6, 2003
Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantationSimona Soverini, Michele Cavo, Claudia Cellini, et al.Pageof 3